Skip to main content
Nanalysis Scientific logo

Nanalysis Scientific — Investor Relations & Filings

Ticker · NSCI ISIN · CA63000Y1034 LEI · 529900FGAUUTMJRG1255 TSXV Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2022-01-27 Capital/Financing Update
Country CA Canada
Listing TSXV NSCI

About Nanalysis Scientific

https://www.nanalysis.com/

Nanalysis Scientific Corp. is a global developer and manufacturer of compact Magnetic Resonance (MR) technologies, primarily focusing on benchtop Nuclear Magnetic Resonance (NMR) spectrometers and analyzers. The company's proprietary instruments, such as the Nanalysis-60 and Nanalysis-100 platforms, offer accessible, affordable, and automatable high-performance alternatives to traditional high-field NMR systems. This technology democratizes NMR spectroscopy for use in laboratory and industrial settings, including applications in quality assurance/quality control (QA/QC), process analytical technology (PAT), synthetic chemistry, pharmaceuticals, polymers, and academic teaching globally.

Recent filings

Filing Released Lang Actions
News release - English.PDF
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding the upsizing of a marketed public offering by Nanalysis Scientific Corp. It details the terms of the offering, the securities involved, the use of proceeds, and regulatory compliance aspects. There are no financial statements or detailed financial performance data presented. The content focuses on capital raising activities and financing updates. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 5790 characters, which is sufficient for a detailed announcement but does not constitute a full financial report.
2022-01-27 English
Material change report - English.PDF
Capital/Financing Update Classification · 95% confidence The document is a FORM 51-102F3 MATERIAL CHANGE REPORT filed by Nanalysis Scientific Corp. It announces a material change related to a public offering of common shares, including details about the offering size, price, agents involved, and regulatory approvals. The document is a regulatory filing reporting a material change event, specifically a capital raising activity. It is not a full financial report, earnings release, or management discussion. The document length is 6435 characters, which is sufficient for a detailed material change report. The content focuses on the announcement of a financing event rather than the financing report itself. According to the filing definitions, updates on company fundraising or financing activities fall under Capital/Financing Update (CAP). Therefore, the appropriate classification is CAP with high confidence.
2022-01-24 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Nanalysis Scientific Corp. has been named to the 2022 OTCQX Best 50, which is a ranking of top performing companies on the OTCQX market. It contains no financial statements, no detailed financial performance data, no regulatory filings, no voting results, no management or board changes, no legal proceedings, no capital or financing updates, and no earnings or interim report data. The document is a general corporate announcement about an award or recognition, not a financial report or regulatory filing. It is also relatively short (4479 characters) and does not mention any report being attached or published. Therefore, it does not fit into any specific financial report category and best fits into the fallback category of Regulatory Filings (RNS) as a general regulatory announcement or corporate news release.
2022-01-24 English
News release - English.pdf
M&A Activity Classification · 95% confidence The document is a press release announcing that Nanalysis Scientific Corp. has entered into a letter of intent to acquire Quad Systems AG. It details the terms of the acquisition, strategic rationale, and background information about both companies. There are no financial statements, quarterly or annual results, or detailed financial analysis included. The document is not a full financial report, audit report, or earnings release. It is an announcement of a corporate transaction (acquisition) and related strategic update. Therefore, the most appropriate classification is M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2022-01-18 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and contains detailed information about securities distribution, including issuer details, distribution dates, purchaser information, types of securities distributed, and jurisdictional summaries. It is a regulatory filing related to exempt distributions of securities, which is a compliance and disclosure document required by securities regulators. The form is not an annual report, earnings release, or management discussion, but a specific regulatory report on exempt distributions. It does not contain financial statements or management analysis but is a formal regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and detailed form content support this classification with high confidence.
2022-01-17 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Nanalysis Scientific Corp. It announces the closing of an acquisition, which is a material change event. The form and content indicate it is a regulatory announcement about a significant corporate event (acquisition closure), not a full merger filing or detailed financial report. The document is short (1349 characters) and serves as a formal notification of a material change rather than a detailed merger or acquisition filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about a material corporate event.
2022-01-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.